These results collectively suggest that SA14 inhibits the acquisition of immune‐suppressive activities, CSC‐like properties and chemoresistance of CRC cells, at least in part, by suppressing STAT3‐mediated PD‐L1 expression. This evidence concerns the gene CD274 and colorectal carcinoma.